Search

Search Constraints

You searched for: Author/Creator Forman, Stephen

Search Results

11. IMMU-09. HETEROGENEOUS INTRA-TUMORAL ANTIGEN EXPRESSION IN RELATION TO IMMUNOTHERAPY OF HIGH GRADE GLIOMA. (5th November 2018)

13. Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia: a report from the Blood or Marrow Transplant Survivor Study-2. Issue 12 (December 2018)

14. Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation. Issue 5 (16th April 2022)

15. Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351). Issue 6 (8th April 2021)

16. P855 High-resolution maps of heterogeneous antigen expression in glioblastoma and implications for immunotherapy. (15th April 2020)

18. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Issue 1 (December 2016)

19. Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults With Cancer. Issue 5 (22nd March 2019)

20. Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia. (21st December 2021)